By Joy Odor Reportcircle News
Nigeria is quietly rewiring the engine room of its health research system, and the message from Abuja is unmistakable: science without ethics will no longer pass.
At the 2026 Face-to-Face Meeting and Training Workshop of the National Health Research Ethics Committee (NHREC), the Federal Government reaffirmed its resolve to enforce rigorous ethical standards across Nigeria’s rapidly expanding health research landscape from clinical trials and drug development to vaccine innovation.
Speaking at the gathering, the Minister of State for Health and Social Welfare, Dr. Iziaq Adekunle Salako, positioned ethical oversight not as a bureaucratic hurdle but as the backbone of credible science, public trust and international relevance.
“As Nigeria expands its footprint in clinical trials and biomedical research, ethical governance must remain central,” Salako said. “It is the only way to protect research participants and preserve scientific integrity.”
A system built, then strengthened
Health research ethics in Nigeria, Salako reminded participants, did not emerge overnight.
The sector gained formal structure with the establishment of NHREC in 2005, before receiving full legal force under the National Health Act of 2014.
That law empowered the committee to approve research involving human subjects, issue national guidelines and monitor compliance to protect the rights, safety and wellbeing of participants.
Nearly two decades later, the government is signaling that ethics enforcement is entering a more mature, technology-driven phase.
Salako commended the current NHREC leadership under Professor Richard Adegbola, citing improved turnaround times for proposal reviews and tighter regulatory oversight.
He described the 2026 workshop as a symbolic milestone, marking the second anniversary of the reconstituted committee inaugurated in January 2024.
Digital shift changes the rules
The defining moment of the Minister’s address came with the unveiling of NHREC’s fully digitised ethics review process, a reform he described as a “game changer” for Nigeria’s research ecosystem.
The revamped NHREC website and newly introduced electronic ethics review portal are expected to replace paper-heavy processes with real-time submissions, performance tracking and improved data management.
According to Salako, the platform will boost efficiency, cut costs, enhance transparency and deepen stakeholder engagement across federal, state and institutional ethics committees.
“This digital transformation is not cosmetic,” he said. “It is about accountability, speed and credibility in a system that must now operate at global standards.”
He urged researchers, universities, sub-national ethics committees and international collaborators to fully adopt the e-portal, warning that ethical compliance can no longer lag behind scientific ambition.
The Minister also acknowledged the role of international partners in strengthening Nigeria’s ethics infrastructure, including the Bill & Melinda Gates Foundation, the US Centers for Disease Control and Prevention, the World Health Organization’s African Vaccine Regulatory Forum (AVAREF), the Multi-Regional Clinical Trials (MRCT) Centre and GARNET partners.
He singled out the ongoing Trial Regulation and Clinical Ethics Optimization (TRACE) project as a strategic intervention designed to improve the safety, rigour and global credibility of clinical trials conducted in Nigeria.
Yet, Salako was clear that external support does not dilute local responsibility.
Under President Bola Ahmed Tinubu’s Renewed Hope Agenda, he said, the Federal Government will continue to encourage and fund domestic research in drug development, vaccines and disease epidemiology but only within an ethically compliant environment capable of delivering real public value.
“Investment in research can only yield results if it is grounded in strong ethical governance,” he said.
As he formally declared the 2026 NHREC meeting and training workshop open, Salako framed the reforms in broader terms: public confidence.
Stronger ethics oversight, he argued, will not only protect research participants but also elevate Nigeria’s standing in global health research and attract high-quality collaborations.
For a country seeking to move from research consumer to research leader, the signal from Abuja is clear ethics is no longer an afterthought.
It is now the gate through which Nigerian science must pass.
